IDEA-FAST and Mobilise-D join forces to strengthen research and development of digital biomarkers

From January 2021 onwards, two EU Innovative Medicines Initiatives, IDEA-FAST and Mobilise-D, will join forces to increase the impact and the benefits of digital health technologies developed by both projects. Acknolwedgment The IDEA-FAST project is a 5½-year IMI2 project under Call H2020-JTI-IMI2-2018-15-two-stage – digital endpoints in neurodegenerative and immune-mediated diseases (total budget €42 Million). It […]

New Blog post on benefits of IDEA-FAST outcomes

Professor Walter Maetzler from Universitätsklinikum Schleswig-Holstein wrote a blog post on his personal motivation for participating in the IDEA-FAST project and the potential impact our project can have on defining and measuring fatigue. Is it really possible to measure fatigue with small portable electronic devices that we can almost buy in the supermarket these days? […]

New Blog post on health and remote monitoring

Mayca Marín, Marta Burgos and from Asociación Parkinson Madrid wrote a new blog post on the impact that the Covid-19 pandemic had (and continues to have) on people affected by Parkinson’s, as well as on the opportunities provided by technology to help manage their disease and therapies remotely, and remarks that can be extrapolated to […]

Health and remote monitoring

There is no doubt that the global pandemic caused by COVID-19 has impacted all sectors of society and the whole population, especially citizens affected by chronic diseases. In this article we would like emphasise the impact that the pandemic had (and continues to have) on people affected by Parkinson’s, as well as on the opportunities […]